Profile data is unavailable for this security.
About the company
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
- Revenue in USD (TTM)866.79k
- Net income in USD-9.13m
- Incorporated2021
- Employees--
- LocationMangoceuticals Inc15110 Dallas Pkwy, Suite 600DALLAS 75248United StatesUSA
- Websitehttps://www.mangorx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avalon Globocare Corp | 1.30m | -14.54m | 3.63m | 5.00 | -- | -- | -- | 2.80 | -1.32 | -1.32 | 0.1176 | 0.3839 | 0.0517 | -- | 11.49 | 259,018.00 | -58.06 | -100.94 | -81.85 | -134.51 | 17.21 | 24.44 | -1,122.68 | -1,011.06 | -- | -0.4168 | 0.6497 | -- | 4.45 | -4.28 | -40.03 | -- | -51.83 | -- |
| Mitesco Inc | 6.00k | -4.15m | 3.82m | 3.00 | -- | -- | -- | 635.86 | -0.6434 | -0.6121 | 0.0004 | -2.54 | 0.0332 | -- | -- | 2,000.00 | -1,094.48 | -246.54 | -- | -- | 0.00 | -- | -33,009.50 | -29,214.62 | -- | -0.7877 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
| Syra Health Corp | 7.07m | -4.19m | 3.82m | 78.00 | -- | 1.23 | -- | 0.541 | -0.6709 | -0.6709 | 1.19 | 0.3169 | 2.81 | -- | 11.27 | 90,635.38 | -166.37 | -- | -287.17 | -- | 23.56 | -- | -59.23 | -- | -- | -177.32 | 0.0518 | -- | -1.83 | -- | -38.72 | -- | -- | -- |
| Novo Integrated Sciences Inc | 13.52m | -24.33m | 4.71m | 127.00 | -- | 0.4727 | -- | 0.3482 | -1.38 | -1.38 | 0.7955 | 0.5225 | 0.3804 | 8.21 | 7.55 | 106,432.80 | -68.51 | -29.43 | -113.88 | -35.64 | 37.68 | 39.59 | -180.11 | -110.25 | 0.2227 | -0.6679 | 0.2093 | -- | 7.11 | 7.17 | 59.77 | -- | -22.73 | -- |
| CompuMed Inc | 1.78m | -151.00k | 4.73m | 8.00 | -- | 36.33 | -- | 2.66 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Medical Care Technologies Inc. | 0.00 | -1.07m | 4.96m | 0.00 | -- | -- | -- | -- | -553,570.10 | -553,570.10 | 0.00 | -389.23 | 0.00 | -- | -- | -- | -154.94 | -- | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -40.06 | -- | -- | -- |
| Ethema Health Corp | 5.27m | 943.69k | 5.41m | 65.00 | 3.18 | -- | 5.31 | 1.03 | 0.0002 | 0.0002 | 0.0014 | -0.0022 | 0.6511 | -- | 14.17 | 81,064.16 | 7.10 | -37.68 | -- | -- | -- | -- | 10.91 | -94.87 | -- | -1.77 | 7.30 | -- | 10.87 | 65.34 | 652.41 | -- | 74.97 | -- |
| Mangoceuticals Inc | 866.79k | -9.13m | 6.01m | -- | -- | 0.4235 | -- | 6.93 | -0.4388 | -0.4388 | 0.041 | 0.4747 | 0.0935 | 19.32 | -- | -- | -98.48 | -- | -107.62 | -- | 58.19 | -- | -1,052.90 | -- | 0.3653 | -38.86 | 0.0134 | -- | 8,082.22 | -- | -361.07 | -- | -- | -- |
| Selectis Health Inc | 37.33m | -6.17m | 6.13m | 574.00 | -- | -- | -- | 0.1643 | -2.02 | -2.02 | 12.19 | -1.05 | 0.8922 | -- | 15.67 | 65,027.49 | -14.67 | -3.03 | -25.30 | -3.58 | -- | -- | -16.44 | -4.84 | -- | -2.98 | 1.11 | -- | -9.40 | 58.97 | -64.93 | -- | -47.72 | -- |
| Kindly MD Inc | 3.10m | -2.44m | 6.39m | 23.00 | -- | 1.46 | -- | 2.06 | -0.4652 | -0.4652 | 0.5743 | 0.7376 | 0.9867 | 5.94 | 471.36 | 134,643.90 | -77.81 | -- | -99.26 | -- | 93.94 | -- | -78.86 | -- | 5.36 | -5.61 | 0.0517 | -- | -0.488 | -- | 36.34 | -- | -- | -- |
| NewGenIvf Group Ltd | 0.00 | -690.85k | 6.45m | -- | -- | 0.1518 | -- | -- | -0.1999 | -0.1999 | 0.00 | 4.19 | 0.00 | -- | -- | -- | -1.50 | -- | -1.54 | -- | -- | -- | -- | -- | -- | -- | 0.0944 | -- | -- | -- | -237.99 | -- | -- | -- |
| Caremax Inc | 784.55m | -782.86m | 6.83m | 1.45k | -- | -- | -- | 0.0087 | -208.41 | -208.41 | 208.34 | -38.73 | 0.9776 | -- | 6.10 | 541,069.60 | -97.55 | -- | -160.21 | -- | -3.31 | -- | -99.78 | -- | -- | -1.95 | 1.57 | -- | 19.01 | -- | -1,707.99 | -- | -- | -- |
| Elite Health Systems Inc | 0.00 | -1.02m | 8.40m | 2.00 | -- | 4.20 | -- | -- | -0.0928 | -0.0928 | 0.00 | 0.1482 | 0.00 | -- | -- | 0.00 | -45.80 | -14.62 | -66.91 | -19.89 | -- | -- | -- | -36.77 | -- | -- | 0.00 | -- | -- | -- | 38.97 | -- | -- | -- |
| Xcelerate Inc | 3.96m | -296.19k | 8.55m | 1.00 | -- | 6.15 | -- | 2.16 | -0.0014 | -0.0014 | 0.0189 | 0.0032 | 1.51 | 6.13 | 3.90 | -- | -11.33 | 4.24 | -49.19 | -- | 71.71 | 74.10 | -7.48 | 1.93 | 0.4797 | -0.8218 | 0.7237 | -- | 6.63 | 10.43 | 17.00 | -- | 174.06 | -- |
Data as of Oct 09 2024. Currency figures normalised to Mangoceuticals Inc's reporting currency: US Dollar USD
1.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Citadel Securities LLCas of 31 Mar 2024 | 114.40k | 0.46% |
| Mercer Global Advisors, Inc.as of 31 Mar 2024 | 100.00k | 0.40% |
| Virtu Americas LLCas of 30 Jun 2024 | 98.70k | 0.40% |
| XTX Markets LLCas of 31 Mar 2024 | 24.35k | 0.10% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 22.00k | 0.09% |
| UBS Securities LLCas of 31 Mar 2024 | 14.45k | 0.06% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 10.36k | 0.04% |
| McCollum Christoferson Group LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| BFSG LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
